Insulet Artificial Pancreas Early Feasibility Study

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

March 31, 2017

Conditions
Type 1 Diabetes
Interventions
DEVICE

Insulet Artificial Pancreas (AP) System

Trial Locations (4)

80045

University of Colorado Denver, Denver

93105

William Sansum Diabetes Center, Santa Barbara

94305

Stanford University, Palo Alto

94598

Diablo Clinical Research, Walnut Creek

Sponsors
All Listed Sponsors
lead

Insulet Corporation

INDUSTRY

NCT02897557 - Insulet Artificial Pancreas Early Feasibility Study | Biotech Hunter | Biotech Hunter